Evidence map›Paper›PMID 22194598›Full record

ArticleThe Journal of biological chemistry2012

Identification of mono- and disulfated N-acetyl-lactosaminyl Oligosaccharide structures as epitopes specifically recognized by humanized monoclonal antibody HMOCC-1 raised against ovarian cancer.

Toshiaki K Shibata, Fumiko Matsumura, Ping Wang, Shinyi Yu, Chi-Chi Chou, Kay-Hooi Khoo, Kazuko Kitayama, Tomoya O Akama, Kazuhiro Sugihara, Naohiro Kanayama and 6 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Characterization of H type 1 and type 1The Journal of biological chemistry · 2017
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 5 institutions in 4 countries.

Toshiaki K ShibataTumor Microenvironment Program, Cancer Center, Sanford-Burnham Medical Research Institute, La Jolla, California 920137, USA.
Fumiko Matsumura
Ping Wang
Shinyi Yu
Chi-Chi Chou
Kay-Hooi Khoo
Kazuko Kitayama
Tomoya O Akama
Kazuhiro Sugihara
Naohiro Kanayama
Kyoko Kojima-Aikawa
Peter H Seeberger
Minoru Fukuda
Atsushi Suzuki
Daisuke Aoki
Michiko N Fukuda
Sanford Burnham Prebys Medical Discovery Institute · USInstitute of Biological Chemistry, Academia Sinica · TWHamamatsu University School of Medicine · JPKeio University Hospital · JPOchanomizu University · JP

Funding

GLYCOPROTEINS IN NORMAL &LEUKEMIC CELL DIFFERENTIATIONR01CA033895 · NCI · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI FUKUDA, MINORU · 1985 to 2010
$3.7M
Biosynthetic pathway of corneal keratan sulfateR01EY014620 · NEI · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI AKAMA, TOMOYA O · 2003 to 2010
$2.7M
NCI NIH HHS CA33895NCI NIH HHS R01 CA033895NEI NIH HHS EY014620NEI NIH HHS R01 EY014620
6 · The paper itself

Abstract

A humanized monoclonal antibody raised against human ovarian cancer RMG-I cells and designated as HMOCC-1 (Suzuki, N., Aoki, D., Tamada, Y., Susumu, N., Orikawa, K., Tsukazaki, K., Sakayori, M., Suzuki, A., Fukuchi, T., Mukai, M., Kojima-Aikawa, K., Ishida, I., and Nozawa, S. (2004) Gynecol. Oncol. 95, 290-298) was characterized for its carbohydrate epitope structure. Specifically, a series of co-transfections was performed using mammalian expression vectors encoding specific glycosyltransferases and sulfotransferases. These experiments identified one sulfotransferase, GAL3ST3, and one glycosyltransferase, B3GNT7, as required for HMOCC-1 antigen formation. They also suggested that the sulfotransferase CHST1 regulates the abundance and intensity of HMOCC-1 antigen. When HEK293T cells were co-transfected with GAL3ST3 and B3GNT7 expression vectors, transfected cells weakly expressed HMOCC-1 antigen. When cells were first co-transfected with GAL3ST3 and B3GNT7 and then with CHST1, the resulting cells strongly expressed HMOCC-1 antigen. However, when cells were transfected with a mixture of GAL3ST3 and CHST1 before or after transfection with B3GNT7, the number of antigen-positive cells decreased relative to the number seen with only GAL3ST3 and B3GNT7, suggesting that CHST1 plays a regulatory role in HMOCC-1 antigen formation. Because these results predicted that HMOCC-1 antigens are SO(3) → 3Galβ1 → 4GlcNAcβ1 → 3(±SO(3) → 6)Galβ1 → 4GlcNAc, we chemically synthesized mono- and disulfated and unsulfated oligosaccharides. Immunoassays using these oligosaccharides as inhibitors showed the strongest activity by disulfated tetrasaccharide, weak but positive activity by monosulfated tetrasaccharide at the terminal galactose, and no activity by nonsulfated tetrasaccharides. These results establish the HMOCC-1 epitope, which should serve as a useful reagent to further characterize ovarian cancer.

Indexed as

Amino SugarsAnimalsAntibodies, MonoclonalAntibody SpecificityCarbohydrate SequenceCarbohydrate SulfotransferasesCHO CellsCricetinaeDisulfidesEpitope MappingEpitopesFemaleHEK293 CellsHumansMolecular Sequence DataN-AcetylglucosaminyltransferasesAmino SugarsAntibodies, MonoclonalB3GNT7 protein, humanCarbohydrate SulfotransferasesDisulfidesEpitopesgalactose-3-O-sulfotransferase 3N-AcetylglucosaminyltransferasesN-acetyllactosamineN-Acetylneuraminic AcidOligosaccharidesRNA, Small InterferingSulfotransferases

Identifiers

PMID22194598
PMCPMC3307324
OpenAlexW2072662046

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.